Cancer Stem Cells Market Size To Reach $3.1 Billion By 2030

Cancer Stem Cells Market Growth & Trends

The global cancer stem cells market size is expected to reach USD 3.1 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 12.09% during the forecast period. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D for the development of effective and novel treatment methods based on stem cells.

Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market.

Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome.

 Request a free sample copy or view report summary: Cancer Stem Cells Market Report

Cancer Stem Cells Market Report Highlights

• Nutraceuticals dominated the market in 2022 with a revenue share of 60%, owing to the changing consumer preferences from chemical-based ingredients to organic and herbal ingredients in dietary supplements

• Online stores is anticipated to be the fastest-growing distribution channel segment over the forecast period, owing to the increase in penetration of e-commerce and the rising number of players offering their products online

• North America dominated the Cancer Stem Cells market for cannabidiol consumer health products, with a revenue share of around 70% in 2022.

Cancer Stem Cells Market Segmentation

Grand View Research has segmented the global cancer stem cells market on the basis of mode of action, cancer forms, and region

Cancer Stem Cells Mode of Action Outlook (Revenue, USD Million, 2018 - 2030)

• Targeted Cancerous Stem Cells (CSCs)

  • By Anti-Cancer Stem Cell Therapeutics

    • Pathway Inhibitors

      • WNT Signaling Pathway

      • Hedgehog Signaling Pathway

      • Notch Signaling Pathway

      • Others

    • Surface Marker-based

    • Immuno-evasion & Targeting Tumor Microenvironment

    • Nanoparticle-based Therapies

    • Others

  • By Products

    • Cell Culturing

    • Cell Separation

    • Cell Analysis

    • Molecular Analysis

    • Others

• Stem Cell-based Cancer Therapy

  • Autologous Stem Cell Transplant

  • Allogeneic Stem Cell Transplant

Cancer Stem Cells Cancer Forms Outlook (Revenue, USD Million, 2018 - 2030)

• Breast Cancer

• Blood Cancer

• Lung Cancer

• Brain Cancer

• Colorectal Cancer

• Pancreatic Cancer

• Bladder Cancer

• Liver Cancer

• Other Cancer

Cancer Stem Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in the Cancer Stem Cells Market

• Thermo Fisher Scientific, Inc.

• AbbVie, Inc.

• Merck KGaA

• Bionomics

• Lonza

• Stemline Therapeutics, Inc.

• Miltenyi Biotec

• PromoCell GmbH

• MacroGenics, Inc.

• OncoMed Pharmaceuticals, Inc.

• FUJIFILM Irvine Scientific

• STEMCELL Technologies.

• Sino Biological, Inc.

• Lineage Cell Therapeutics, Inc.